Erratum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity (Nature (2014) 505 (691-695) (DOI:10.1038/nature12862));Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity

Nature

Volumn 505, Issue 7485, 2014, Pages 691-695

  Schoggins, John W ^a,k   MacDuff, Donna A ^b   Imanaka, Naoko ^a   Gainey, Maria D ^b   Shrestha, Bimmi ^b   Eitson, Jennifer L ^c   Mar, Katrina B ^c   Richardson, R Blake ^c   Ratushny, Alexander V ^d,e   Litvak, Vladimir ^d   Dabelic, Rea ^f   Manicassamy, Balaji ^g   Aitchison, John D ^d,e   Aderem, Alan ^d   Elliott, Richard M ^h   García Sastre, Adolfo ⁱ   Racaniello, Vincent ^f   Snijder, Eric J ^j   Yokoyama, Wayne M ^b   Diamond, Michael S ^b   Virgin, Herbert W ^b   Rice, Charles M ^a,k   more..

^a ROCKEFELLER UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h UNIVERSITY OF ST ANDREWS   (United Kingdom)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; SINGLE STRANDED RNA; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3;

BIOASSAY; COMPARATIVE STUDY; DNA; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNITY; INHIBITION; PARADIGM SHIFT; SIGNALING; VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; GENE ACTIVATION; GENE CLUSTER; GENE EXPRESSION; GENETIC TRANSCRIPTION; INNATE IMMUNITY; INTERFERON STIMULATED GENE; MB21D1 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA VIRUS; SIGNAL TRANSDUCTION; VIRUS INFECTIVITY;

DNA VIRUSES; MURINAE; RNA VIRUSES;

EID: 84895904323     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14555     Document Type: Erratum

References (39)

1. Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. Identification of genes differentially regulated by interferon a, b, or c using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95, 15623-15628 (1998).
2. de Veer, M. J. et al. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69, 912-920 (2001).
3. Schoggins, J. W. & Rice, C. M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519-525 (2011).
4. Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
5. Liu, S. Y., Sanchez, D. J., Aliyari, R., Lu, S. & Cheng, G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc. Natl Acad. Sci. USA 109, 4239-4244 (2012).
6. Metz, P. et al. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology 56, 2082-2093 (2012).
7. Fusco, D. N. et al. A genetic screen identifies interferon-a effector genes required to suppress hepatitis C virus replication. Gastroenterology 144, 1438-1449 (2013).
8. Zhao, H. et al. A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitisCvirus. J.Hepatol. 56, 326-333 (2012).
9. Zhang, Y., Burke, C. W., Ryman, K. D. & Klimstra, W. B. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81, 11246-11255 (2007).
10. Wilson, S. J. et al. Inhibition of HIV-1 particle assembly by 29,39-cyclic-nucleotide 39-phosphodiesterase. Cell Host Microbe 12, 585-597 (2012).
11. Schoggins, J. W. et al. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc. Natl Acad. Sci. USA 109, 14610-14615 (2012).
12. Karki, S. et al. Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. PLoS ONE 7, e37398 (2012).
13. Meng, X. et al. C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. J. Virol. 86, 4538-4547 (2012).
14. Dupuis, S. et al. Impaired response to interferon-a/b and lethal viral disease in human STAT1 deficiency. Nature Genet. 33, 388-391 (2003).
15. Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
16. Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826-830 (2013).
17. Kranzusch, P. J., Lee, A. S.-Y., Berger, J. M.&Doudna, J. A. Structure of humancGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep. 3, 1362-1368 (2013).
18. Gao, P. et al. Cyclic [G(29,59)pA(39,59)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153, 1094-1107 (2013).
19. Civril, F. et al. Structuralmechanismof cytosolicDNAsensing bycGAS.Nature498, 332-337 (2013).
20. Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906 (2013).
21. Li, X. D. et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390-1394 (2013).
22. Suthar, M. S. et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6, e1000757 (2010).
23. Errett, J. S., Suthar, M. S., McMillan, A., Diamond, M. S. & Gale, M. Jr. The essential, non-redundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J. Virol. 87, 11416-11425 (2013).
24. Feuer, R., Mena, I., Pagarigan, R., Slifka, M. K.&Whitton, J. L. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76, 4430-4440 (2002).
25. Teterina, N. L., Levenson, E. A. & Ehrenfeld, E. Viable polioviruses that encode 2A proteins with fluorescent protein tags. J. Virol. 84, 1477-1488 (2010).
26. van den Born, E., Posthuma, C. C., Knoops, K. & Snijder, E. J. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J. Gen. Virol. 88, 1196-1205 (2007).
27. Simmons, J. D., Wollish, A. C. & Heise, M. T. A determinant of Sindbis virus neurovirulence enables efficient disruption of Jak/STAT signaling. J. Virol. 84, 11429-11439 (2010).
28. Brault, A. C. et al. Infection patterns of o'nyong nyong virus in the malariatransmitting mosquito, Anopheles gambiae. Insect Mol. Biol. 13, 625-635 (2004).
29. Manicassamy, B. et al. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl Acad. Sci. USA 107, 11531-11536 (2010).
30. Zhang, L. et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol. 79, 1113-1124 (2005).
31. Park, M. S. et al. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for theNDV V protein and the Nipah virus V, W, andC proteins. J. Virol. 77, 1501-1511 (2003).
32. Biacchesi, S. et al. Recovery of humanmetapneumovirus fromcDNA: optimization of growth in vitro and expression of additional genes. Virology 321, 247-259 (2004).
33. del Valle, J. R. et al. A vectored measles virus induces hepatitis B surface antigen antibodies while protectingmacaques againstmeasles virus challenge. J. Virol. 81, 10597-10605 (2007).
34. Shi, X., van Mierlo, J. T., French, A. & Elliott, R. M. Visualizing the replication cycle of bunyamwera orthobunyavirus expressing fluorescent protein-tagged Gc glycoprotein. J. Virol. 84, 8460-8469 (2010).
35. Ebel, G. D., Carricaburu, J., Young, D., Bernard, K. A. & Kramer, L. D. Genetic and phenotypic variation of West Nile virus in New York, 2000-2003. Am. J. Trop. Med. Hyg. 71, 493-500 (2004).
36. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815 (2013).
37. Kanki, H., Suzuki, H.& Itohara, S. High-efficiency CAG-FLPe deleter mice in C57BL/6J background. Exp. Anim. 55, 137-141 (2006).
38. Hwang, S. et al. Nondegradative role of Atg5-Atg12/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe 11, 397-409 (2012).
39. Daffis, S., Samuel, M. A., Keller, B. C., Gale, M., Jr. & Diamond, M. S. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and-independent mechanisms. PLoS Pathog. 3, e106 (2007).